Literature DB >> 18580720

Report of the International Society for Clinical Densitometry 2007 Adult Position Development Conference and Official Positions.

E Michael Lewiecki1, Sanford Baim, Neil Binkley, John P Bilezikian, David L Kendler, Didier B Hans, Stuart Silverman.   

Abstract

The International Society for Clinical Densitometry (ISCD) periodically holds Position Development Conferences (PDCs) for the purpose of establishing standards and guidelines for the assessment of skeletal health -- the nomenclature, indications, acquisition, analysis, quality control, interpretation, and reporting of bone density tests. Topics are selected for consideration according to criteria that include clinical relevancy, uncertainty in the application of medical evidence to clinical practice, and the likelihood of the expert panel achieving agreement. The most recent Adult PDC was held July 20 to 22, 2007, in Lansdowne, Virginia. Topics included technical and clinical issues relevant to dual-energy x-ray absorptiometry (DXA), vertebral fracture assessment, and bone densitometry technologies other than central DXA. This report describes the methodology and presents the results of this PDC. The first ISCD Pediatric PDC was held June 20 to 21, 2007 in Montreal, Quebec, Canada, and is reported separately.

Entities:  

Mesh:

Year:  2008        PMID: 18580720     DOI: 10.1097/SMJ.0b013e31817a8b02

Source DB:  PubMed          Journal:  South Med J        ISSN: 0038-4348            Impact factor:   0.954


  15 in total

1.  Moderate weight loss in obese and overweight men preserves bone quality.

Authors:  L Claudia Pop; Deeptha Sukumar; Katherine Tomaino; Yvette Schlussel; Stephen H Schneider; Chris L Gordon; Xiangbing Wang; Sue A Shapses
Journal:  Am J Clin Nutr       Date:  2015-01-07       Impact factor: 7.045

2.  Gender aspects of osteoporosis and bone strength.

Authors:  Janina M Patsch; Julia Deutschmann; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2011-03

3.  High frequency of osteoporosis and fractures in women with dermatomyositis/polymyositis.

Authors:  Danieli Castro Oliveira de Andrade; Sonia Cristina de Magalhães Souza; Jozélio Freire de Carvalho; Liliam Takayama; Claudia Teresa Lobato Borges; José Mendes Aldrighi; Rosa Maria Rodrigues Pereira
Journal:  Rheumatol Int       Date:  2011-02-16       Impact factor: 2.631

Review 4.  Noninvasive imaging of bone microarchitecture.

Authors:  Janina M Patsch; Andrew J Burghardt; Galateia Kazakia; Sharmila Majumdar
Journal:  Ann N Y Acad Sci       Date:  2011-12       Impact factor: 5.691

5.  Dipeptidyl Peptidase 3 Activity as a Promising Biomarker of Bone Fragility in Postmenopausal Women.

Authors:  Ciro Menale; Gaia Tabacco; Anda Mihaela Naciu; Maria Lucia Schiavone; Francesca Cannata; Emanuela Morenghi; Cristina Sobacchi; Andrea Palermo
Journal:  Molecules       Date:  2022-06-19       Impact factor: 4.927

6.  Infliximab therapy increases body fat mass in early rheumatoid arthritis independently of changes in disease activity and levels of leptin and adiponectin: a randomised study over 21 months.

Authors:  Inga-Lill Engvall; Birgitta Tengstrand; Kerstin Brismar; Ingiäld Hafström
Journal:  Arthritis Res Ther       Date:  2010-10-21       Impact factor: 5.156

7.  Bone mineral density and body composition in male children with hypogonadism.

Authors:  D Fintini; A Grossi; C Brufani; R Fiori; G Ubertini; L Pecorelli; M Cappa
Journal:  J Endocrinol Invest       Date:  2009-06-15       Impact factor: 4.256

8.  Reproducibility of DXA-based bone strain index and the influence of body mass: an in vivo study.

Authors:  Carmelo Messina; Luca Petruccio Piodi; Luca Rinaudo; Ciriaco Buonomenna; Luca Maria Sconfienza; Laura Vergani; Fabio Massimo Ulivieri
Journal:  Radiol Med       Date:  2019-12-27       Impact factor: 3.469

9.  DXA-Based Bone Strain Index: A New Tool to Evaluate Bone Quality in Primary Hyperparathyroidism.

Authors:  Gaia Tabacco; Anda M Naciu; Carmelo Messina; Gianfranco Sanson; Luca Rinaudo; Roberto Cesareo; Stefania Falcone; Silvia Manfrini; Nicola Napoli; John P Bilezikian; Fabio M Ulivieri; Andrea Palermo
Journal:  J Clin Endocrinol Metab       Date:  2021-07-13       Impact factor: 5.958

10.  Low sclerostin levels: a predictive marker of persistent inflammation in ankylosing spondylitis during anti-tumor necrosis factor therapy?

Authors:  Carla G S Saad; Ana C M Ribeiro; Julio C B Moraes; Liliam Takayama; Celio R Goncalves; Marcelo B Rodrigues; Ricardo M de Oliveira; Clovis A Silva; Eloisa Bonfa; Rosa M R Pereira
Journal:  Arthritis Res Ther       Date:  2012-10-12       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.